OxyBUTYnin chloride 3 mg Oral Tablet
RxNorm 863799
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 863799 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: oxyBUTYnin chloride 3 mg Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCD
Semantic Clinical Drug (SCD):
Oxybutynin chloride 3 mg Oral Tablet
(Atom ID: 12343422)
PSN
Prescribable Name (PSN):
OxyBUTYnin chloride 3 mg Oral Tablet
(Atom ID: 6362407)
TMSY
Tall Man Lettering Synonym (TMSY):
OxyBUTYnin chloride 3 mg Oral Tablet
(Atom ID: 12815107)
PT
Designated preferred name (PT):
Oxybutynin chloride 3 mg oral tablet
(Atom ID: 10302678)
SY
Synonym (SY):
Oxybutynin hydrochloride 3 mg oral tablet
(Atom ID: 11825995)
FN
Full form of descriptor (FN):
Product containing precisely oxybutynin hydrochloride 3 mg/1 each conventional release oral tablet (clinical drug)
(Atom ID: 11826565)
Patient Education
Oxybutynin
Oxybutynin is used to treat overactive bladder (a condition in which the bladder muscles contract uncontrollably and cause frequent urination, urgent need to urinate, and inability to control urination) in certain adults and children. Oxybutynin is also used as an extended-release tablet to control bladder muscles in adults and children 6 years of age and older with spina bifida (a disability that occurs when the spinal cord does not close properly before birth), or other nervous system conditions that affect the bladder muscles. Oxybutynin is in a class of medications called anticholinergics/antimuscarinics. It works by relaxing the bladder muscles.
[Learn More]
* Please review the disclaimer below.